Enzyme Replacement Therapy Market | Acumen Research and Consulting

CHAPTER 1. Industry Overview of Enzyme Replacement Therapy Market

1.1. Definition and Scope

1.1.1. Definition of Enzyme Replacement Therapy

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Enzyme Replacement Therapy Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Enzyme Replacement Therapy Market By Enzyme Type

1.2.3. Enzyme Replacement Therapy Market By Indication

1.2.4. Enzyme Replacement Therapy Market By End-user

1.2.5. Enzyme Replacement Therapy Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Enzyme Type

2.2.1. Secondary Enzyme Type

2.2.2. Primary Enzyme Type

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Enzyme Replacement Therapy Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Enzyme Replacement Therapy Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Price Trend of Key Raw Material

3.8.1. Raw Material Suppliers

3.8.2. Proportion of Manufacturing Cost Structure

3.8.2.1. Raw Material

3.8.2.2. Labor Cost

3.8.2.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2022

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022

4.2. R&D Status of Major Manufacturers in 2022

CHAPTER 5. Enzyme Replacement Therapy Market By Enzyme Type

5.1. Introduction

5.2. Enzyme Replacement Therapy Revenue By Enzyme Type

5.2.1. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast, By Enzyme Type, 2020-2032

5.2.2. Agalsidase Beta

5.2.2.1. Agalsidase Beta Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. Taliglucerase

5.2.3.1. Taliglucerase Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4. Velaglucerase Alfa

5.2.4.1. Velaglucerase Alfa Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.5. Idursulfase

5.2.5.1. Idursulfase Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.6. Imiglucerase

5.2.6.1. Imiglucerase Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.7. Alglucosidase Alfa

5.2.7.1. Alglucosidase Alfa Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.8. Pegademase

5.2.8.1. Pegademase Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.9. Laronidase

5.2.9.1. Laronidase Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.10. Galsulfase

5.2.10.1. Galsulfase Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.11. Others

5.2.11.1. OthersMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. Enzyme Replacement Therapy Market By Indication

6.1. Introduction

6.2. Enzyme Replacement Therapy Revenue By Indication

6.2.1. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast, By Indication, 2020-2032

6.2.2. Fabry Disease

6.2.2.1. Fabry DiseaseMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Pompe Disease

6.2.3.1. Pompe Disease Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4. Gaucher Disease

6.2.4.1. Gaucher Disease Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.5. Scheie Syndrome

6.2.5.1. Scheie Syndrome Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.6. Maroteaux-Lamy Syndrome

6.2.6.1. Maroteaux-Lamy Syndrome Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.7. Hunter Disease

6.2.7.1. Hunter DiseaseMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.8. Others

6.2.8.1. OthersMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. Enzyme Replacement Therapy Market By End-user

7.1. Introduction

7.2. Enzyme Replacement Therapy Revenue By End-user

7.2.1. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast, By End-user, 2020-2032

7.2.2. Hospitals

7.2.2.1. HospitalsMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3. Home care setting

7.2.3.1. Home care setting market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4. Clinics

7.2.4.1. ClinicsMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 8. North America Enzyme Replacement Therapy Market By Country 

8.1. North America Enzyme Replacement Therapy Market Overview

8.2. U.S.

8.2.1. U.S. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

8.2.2. U.S. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

8.2.3. U.S. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

8.3. Canada

8.3.1. Canada Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

8.3.2. Canada Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

8.3.3. Canada Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

8.4. North America PEST Analysis

CHAPTER 9. Europe Enzyme Replacement Therapy Market By Country

9.1. Europe Enzyme Replacement Therapy Market Overview

9.2. U.K.

9.2.1. U.K. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

9.2.2. U.K. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

9.2.3. U.K. Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

9.3. Germany

9.3.1. Germany Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

9.3.2. Germany Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

9.3.3. Germany Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

9.4. France

9.4.1. France Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

9.4.2. France Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

9.4.3. France Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

9.5. Spain

9.5.1. Spain Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

9.5.2. Spain Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

9.5.3. Spain Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

9.6. Rest of Europe

9.6.1. Rest of Europe Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

9.6.2. Rest of Europe Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

9.6.3. Rest of Europe Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

9.7. Europe PEST Analysis

CHAPTER 10.  Asia Pacific Enzyme Replacement Therapy Market By Country

10.1. Asia Pacific Enzyme Replacement Therapy Market Overview

10.2. China

10.2.1. China Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

10.2.2. China Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.2.3. China Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

10.3. Japan

10.3.1. Japan Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

10.3.2. Japan Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.3.3. Japan Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

10.4. India

10.4.1. India Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

10.4.2. India Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.4.3. India Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

10.5. Australia

10.5.1. Australia Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

10.5.2. Australia Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.5.3. Australia Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

10.6. South Korea

10.6.1. South Korea Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

10.6.2. South Korea Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.6.3. South Korea Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

10.7.2. Rest of Asia-Pacific Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.7.3. Rest of Asia-Pacific Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

10.8. Asia Pacific PEST Analysis

CHAPTER 11.  Latin America Enzyme Replacement Therapy Market By Country

11.1. Latin America Enzyme Replacement Therapy Market Overview

11.2. Brazil

11.2.1. Brazil Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

11.2.2. Brazil Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

11.2.3. Brazil Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

11.3. Mexico

11.3.1. Mexico Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

11.3.2. Mexico Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

11.3.3. Mexico Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

11.4. Rest of Latin America

11.4.1. Rest of Latin America Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

11.4.2. Rest of Latin America Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

11.4.3. Rest of Latin America Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

11.5. Latin America PEST Analysis

CHAPTER 12.  Middle East & Africa Enzyme Replacement Therapy Market By Country 

12.1. Middle East & Africa Enzyme Replacement Therapy Market Overview

12.2. GCC

12.2.1. GCC Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

12.2.2. GCC Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

12.2.3. GCC Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

12.3. South Africa

12.3.1. South Africa Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

12.3.2. South Africa Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

12.3.3. South Africa Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Enzyme Type, 2020-2032

12.4.2. Rest of Middle East & Africa Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032

12.4.3. Rest of Middle East & Africa Enzyme Replacement Therapy Revenue (USD Billion) and Forecast By End-user, 2020-2032

12.5. Middle East & Africa PEST Analysis

CHAPTER 13.  Player Analysis Of Enzyme Replacement Therapy Market

13.1. Enzyme Replacement Therapy MarketCompany Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment

13.2.2. New ProductLaunches and Product Enhancements

13.2.3. Mergers And Acquisition InGlobal Enzyme Replacement Therapy Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14.  Company Profile

14.1. Sanofi Genzyme

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Billion), 2022

14.1.3.2. Sanofi Genzyme 2022 Enzyme Replacement Therapy Business Regional Distribution

14.1.4. Product /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Shire (part of Takeda Pharmaceuticals)

14.3. BioMarin Pharmaceutical Inc.

14.4. Alexion Pharmaceuticals

14.5. Pfizer Inc.

14.6. AbbVie Inc.

14.7. Amicus Therapeutics

14.8. JCR Pharmaceuticals Co., Ltd.

14.9. Protalix Biotherapeutics, Inc.

14.10. Sangamo Therapeutics, Inc.